Data Foundry

Drug recalls 2023

Norepinephrine 4 mg per 250 mL — Class II drug recall D-0931-2023

Terminated recall by SterRx, LLC, reported 2023-07-26, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0931-2023
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSterRx, LLC, Plattsburgh, NY, United States
Recall initiated2023-07-07
Classified2023-07-19
Reported by FDA2023-07-26
Terminated2024-07-08
DistributedNationwide (US)
Quantity132,299 bags
Reason classessterility
NDC70324-0552-01
Lot numbers490062, 490151, 490732, 491591, 491604, 494418, 494426, 494434, 496755, 497424, 497432, 497441, 497459, 498005, 499075, 499083, 499091, 499391, 501964, 501972, 501981, 501999, 502001
Expiration dates2023-07-22, 2023-07-28, 2023-08-06, 2023-08-17, 2023-08-18, 2023-11-16, 2023-11-17, 2023-11-23, 2023-11-25, 2023-12-03, 2023-12-04, 2023-12-07, 2023-12-10, 2024-01-22, 2024-01-25, 2024-01-26, 2024-03-23, 2024-03-28, 2024-03-30, 2024-04-06, 2024-04-07

Product

Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-552-01.

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0931-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.